Corrigendum to “Clinical and economic impact of the availability of innovative therapies for advanced lung cancer in men in Latin America: a population-based secondary data study”- the Lancet Regional Health—Americas 2025; Volume 49: 101172; DOI: 10.1016/j.lana.2025.101172

Registros relacionados

• Corrigendum to “Healthy Brazil: a multisectoral strategy for tackling neglected diseases and promoting health equity”- The Lancet Regional Health—Americas 2025; Volume 48, 101187; DOI: 10.1016/j.lana.2025.101187
  Publicado em: (2025-10-01)
• Corrigendum to “Clinical and economic impact of the availability of innovative therapies for advanced lung cancer in men in Latin America: a population-based secondary data study”- the Lancet Regional Health—Americas 2025; Volume 49: 101172; DOI: 10.1016/j.lana.2025.101172
  por: Andrés F. Cardona, et al.
  Publicado em: (2025-12-01)
• Corrigendum to “Impact of strategic public health interventions to reduce tuberculosis incidence in Brazil: a Bayesian structural time-series scenario analysis” - The Lancet Regional Health – Americas 2025; Volume 41: 100963; DOI: 10.1016/j.lana.2024.100963
  por: Klauss Villalva-Serra, et al.
  Publicado em: (2026-02-01)
• Corrigendum to “Identifying when racial and ethnic disparities arise along the continuum of transplant care: a national registry study”- The Lancet Regional Health—Americas October 2024; Volume 38: 100895; DOI: 10.1016/j.lana.2024.100895
  por: Maya N. Clark-Cutaia, et al.
  Publicado em: (2025-07-01)
• Corrigendum to ‘Efficacy of the CHRONOlight biodynamic lighting system for control of nosocomial Gram-negative pathogens’ Int J Infect Dis. 2025 Dec;161:108120. doi: 10.1016/j.ijid.2025.108120. Epub 2025 Oct 11.
  por: Patricia Pérez-Palacios, et al.
  Publicado em: (2026-05-01)